"Not a bad time to lighten up on the GLP-1 basket
Assuno M, Martins LL, Mourato MP, Baleiras-Couto MM (2015) Effect of selenium on growth and antioxidant enzyme activities of wine related yeasts
If you experience common side effectssuch as mild injection site discomfort, headaches, or flushingour providers will guide you on optimal injection techniques and may recommend adjustments in dosage or timing to minimise discomfort
As of this writing: The FDA has not published formal reclassification guidance
In contrast, downregulation was not observed in either of the GLP-1RAdosed groups (Figure 8B)
If you have type 2 diabetes requiring glycemic control, pharmaceutical GLP-1 agonists are FDA-approved for this indication and have extensive evidence supporting their use